% alzhub.org library filter
% Source: https://alzhub.org/research?journal=Clinical+Neuropharmacology
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{landen2013-23334070,
  author  = {Landen, J. W. and Zhao, Q. and Cohen, S. and Borrie, M. and Woodward, M. and Billing, C. B. and Bales, K. and Alvey, C. and others},
  title   = {{Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study}},
  journal = {Clinical neuropharmacology},
  year    = {2013},
  doi     = {10.1097/wnf.0b013e31827db49b},
  pmid    = {23334070},
  url     = {https://doi.org/10.1097/wnf.0b013e31827db49b}
}

@article{stryjer2012-22751086,
  author  = {Stryjer, R. and Ophir, D. and Bar, F. and Spivak, B. and Weizman, A. and Strous, R. D.},
  title   = {{Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia}},
  journal = {Clinical neuropharmacology},
  year    = {2012},
  doi     = {10.1097/wnf.0b013e31825e7945},
  pmid    = {22751086},
  url     = {https://doi.org/10.1097/wnf.0b013e31825e7945}
}

@article{siemers2010-20375655,
  author  = {Siemers, E. R. and Friedrich, S. and Dean, R. A. and Gonzales, C. R. and Farlow, M. R. and Paul, S. M. and Demattos, R. B.},
  title   = {{Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease}},
  journal = {Clinical neuropharmacology},
  year    = {2010},
  doi     = {10.1097/wnf.0b013e3181cb577a},
  pmid    = {20375655},
  url     = {https://doi.org/10.1097/wnf.0b013e3181cb577a}
}

@article{lane2004-15190239,
  author  = {Lane, R. M. and Kivipelto, M. and Greig, N. H.},
  title   = {{Acetylcholinesterase and its inhibition in Alzheimer disease}},
  journal = {Clinical neuropharmacology},
  year    = {2004},
  doi     = {10.1097/00002826-200405000-00011},
  pmid    = {15190239},
  url     = {https://doi.org/10.1097/00002826-200405000-00011}
}

@article{koller1989-2720700,
  author  = {Koller, W. C. and Glatt, S. and Vetere-Overfield, B. and Hassanein, R.},
  title   = {{Falls and Parkinson's disease}},
  journal = {Clinical neuropharmacology},
  year    = {1989},
  doi     = {10.1097/00002826-198904000-00003},
  pmid    = {2720700},
  url     = {https://doi.org/10.1097/00002826-198904000-00003}
}

@article{deutsch2003-14520169,
  author  = {Deutsch, S. I. and Rosse, R. B. and Mastropaolo, J. and Chilton, M.},
  title   = {{Progressive worsening of adaptive functions in Down syndrome may be mediated by the complexing of soluble Abeta peptides with the alpha 7 nicotinic acetylcholine receptor: therapeutic implications}},
  journal = {Clinical neuropharmacology},
  year    = {2003},
  doi     = {10.1097/00002826-200309000-00013},
  pmid    = {14520169},
  url     = {https://doi.org/10.1097/00002826-200309000-00013}
}

@article{lehrer2025-41025536,
  author  = {Lehrer, Steven P. and Rheinstein, Peter H.},
  title   = {{Structure-guided Docking of Benzene-1,3-Disulfonic Acid to the ApoE-HSPG Binding Site at Arginine 136 as a Christchurch-mimetic Therapeutic Strategy for Alzheimer Disease}},
  journal = {Clinical Neuropharmacology},
  year    = {2025},
  doi     = {10.1097/wnf.0000000000000649},
  pmid    = {41025536},
  url     = {https://doi.org/10.1097/wnf.0000000000000649}
}